Disease The intractable diseases designated by MHLW, Japan
Diseases : 338 - Clinical trials : 34,520 / Drugs : 19,957 - ( DrugBank : 2,195 ) / Drug target genes : 613 - Drug target pathways : 297
ID | Disease name [Group] | Clinical trial Phase 1 / 2 / 3 / 4 | Drug [ DrugBank ] | Target gene Target pathway | Domestic patients Med expenses recipients (FY2022) |
---|---|---|---|---|---|
1 | Spinal and bulbar muscular atrophy [Neu] 💬 "Spinobulbar muscular atrophy", "SBMA", "Kennedy disease", "Kennedy-Alter-Sung syndrome" | 18 18 trials | 1 / 10 / 2 / 1 💬 | 15 15 drugs [ 8 8 drugs ] | 10 10 genes 17 pathways | 1697 1,697 patientsAge distribution💬 |
2 | Amyotrophic lateral sclerosis [Neu] 💬 "ALS" | 645 645 trials | 227 / 290 / 231 / 26 💬 | 589 589 drugs [ 163 163 drugs ] | 150 150 genes 225 pathways | 9765 9,765 patientsAge distribution💬 |
3 | Spinal muscular atrophy [Neu] 💬 "Myelopathic muscular atrophy", "Spinal muscular atrophy type I", "SMA I", "Werdnig-Hoffman disease", "Spinal muscular atrophy type II", "SMA II", "Dubowitz disease", "Spinal muscular atrophy type III", "SMA III", "Kugelberg-Welander disease", "Spinal muscular atrophy type IV", "SMA IV" | 237 237 trials | 106 / 117 / 116 / 28 💬 | 123 123 drugs [ 29 29 drugs ] | 51 51 genes 75 pathways | 955 955 patientsAge distribution💬 |
4 | Primary lateral sclerosis [Neu] 💬 "PLS" | 5 5 trials | 2 / 2 / 0 / 1 💬 | 13 13 drugs [ 6 6 drugs ] | 13 13 genes 25 pathways | 146 146 patientsAge distribution💬 |
5 | Progressive supranuclear palsy [Neu] 💬 "PSP" | 89 89 trials | 45 / 42 / 9 / 6 💬 | 107 107 drugs [ 40 40 drugs ] | 65 65 genes 108 pathways | 12830 12,830 patientsAge distribution💬 |
6 | Parkinson disease [Neu] 💬 "Disease Parkinson's" | 2,307 2,307 trials | 810 / 703 / 607 / 290 💬 | 2,007 2,007 drugs [ 349 349 drugs ] | 188 188 genes 199 pathways | 143267 143,267 patientsAge distribution💬 |
7 | Corticobasal degeneration [Neu] 💬 "Corticobasal syndrome", "CBD" | 16 16 trials | 5 / 3 / 1 / 0 💬 | 28 28 drugs [ 13 13 drugs ] | 9 9 genes 38 pathways | 4428 4,428 patientsAge distribution💬 |
8 | Huntington disease [Neu] 💬 "Huntington chorea" | 242 242 trials | 111 / 134 / 50 / 13 💬 | 205 205 drugs [ 62 62 drugs ] | 85 85 genes 159 pathways | 892 892 patientsAge distribution💬 |
9 | Neuroacanthocytosis [Neu] 💬 "Choreoacanthocytosis", "Chorea-acanthocytosis", "Levine-Critchley syndrome", "McLeod syndrome", "Huntington disease-like 2", "HDL2", "Pantothenate kinase-associated neurodegeneration", "PKAN", "Hallervorden-Spatz syndrome" | 0 - | 0 - | 0 - | 36 36 patientsAge distribution💬 |
10 | Charcot-Marie-Tooth disease [Neu] 💬 "CMT", "Charcot-Marie-Tooth disease type 1", "CMT1", "Demyelinating CMT", "Charcot-Marie-Tooth disease type 2", "CMT2", "Axonal CMT", "Intermediate Charcot-Marie-Tooth disease", "CMT-I", "Intermediate CMT" | 41 41 trials | 25 / 17 / 24 / 4 💬 | 46 46 drugs [ 9 9 drugs ] | 11 11 genes 15 pathways | 845 845 patientsAge distribution💬 |
11 | Myasthenia gravis [Neu] 💬 "MG", "Generalized myasthenia gravis", "Generalized MG", "GMG", "Systemic myasthenia gravis", "Systemic MG", "Ocular myasthenia gravis", "Ocular MG", "OMG" | 332 332 trials | 110 / 106 / 204 / 29 💬 | 234 234 drugs [ 81 81 drugs ] | 45 45 genes 127 pathways | 26387 26,387 patientsAge distribution💬 |
12 | Congenital myasthenic syndrome [Neu] 💬 "End-plate acetylcholine receptor deficiency", "Slow-channel congenital myasthenic syndrome", "Fast-channel congenital myasthenic syndrome", "Sodium channel myasthenia", "End-plate acetylcholine esterase deficiency", "Congenital myasthenic syndrome with episodic apnoea", "Dok-7 myasthenia", "DOK7 congenital myasthenic syndrome" | 5 5 trials | 1 / 0 / 0 / 0 💬 | 7 7 drugs [ 3 3 drugs ] | 5 5 genes 13 pathways | 12 12 patientsAge distribution💬 |
13 | Multiple sclerosis/Neuromyelitis optica [Neu] 💬 "Multiple sclerosis", "MS", "Neuromyelitis optica", "Neuromyelitis optica spectrum disorder", "NMOSD", "Balo concentric sclerosis", "Baló concentric sclerosis" | 3,340 3,340 trials | 996 / 796 / 1256 / 514 💬 | 2,163 2,163 drugs [ 383 383 drugs ] | 241 241 genes 238 pathways | 23105 23,105 patientsAge distribution💬 |
14 | Chronic inflammatory demyelinating polyneuropathy [Neu] 💬 "Chronic inflammatory demyelinating poly (radiculo) neuropathy", "CIDP", "Multifocal motor neuropathy" | 175 175 trials | 46 / 94 / 76 / 14 💬 | 161 161 drugs [ 41 41 drugs ] | 13 13 genes 24 pathways | 5291 5,291 patientsAge distribution💬 |
15 | Inclusion body myositis [Neu] 💬 | 42 42 trials | 31 / 19 / 25 / 5 💬 | 33 33 drugs [ 11 11 drugs ] | 12 12 genes 123 pathways | 847 847 patientsAge distribution💬 |
16 | Crow-Fukase syndrome [Neu] 💬 "POEMS syndrome", "Polyneuropathy, organomegaly, endocrinopathy, m-protein, and skin changes syndrome", "Takatsuki disease", "PEP syndrome", "Polyneuropathy, endocrinopathy, plasma cell dyscrasia syndrome" | 13 13 trials | 2 / 7 / 2 / 1 💬 | 14 14 drugs [ 7 7 drugs ] | 4 4 genes 75 pathways | 252 252 patientsAge distribution💬 |
17 | Multiple system atrophy [Neu] 💬 "MSA-C", "MSA-P", "Olivopontocerebellar atrophy", "OPCA", "Striatonigral degeneration", "Shy-Drager syndrome" | 119 119 trials | 43 / 40 / 40 / 7 💬 | 138 138 drugs [ 44 44 drugs ] | 59 59 genes 111 pathways | 10808 10,808 patientsAge distribution💬 |
18 | Spinocerebellar degeneration [Neu] 💬 "SCD", "Spinocerebellar ataxia type I", "SCA1", "Spinocerebellar ataxia type II", "SCA2", "Spinocerebellar ataxia type III", "SCA3", "Machado-Joseph disease", "Spinocerebellar ataxia type VI", "SCA6", "Spinocerebellar ataxia type VII", "SCA7", "Spinocerebellar ataxia type X", "SCA10", "Spinocerebellar ataxia type XII", "SCA12", "Dentatorubural pallidoluysian atrophy", "Dentatorubropallidoluysial atrophy", "DRPLA", "Naito-Koyanagi disease", "Friedreich ataxia", "FRDA", "Ataxia with vitamin E deficiency", "AVED", "Early-onset ataxia with ocular motor ataxia and hypoalbuminemia", "EOAH" | 76 76 trials | 20 / 46 / 19 / 5 💬 | 98 98 drugs [ 31 31 drugs ] | 44 44 genes 65 pathways | 26476 26,476 patientsAge distribution💬 |
22 | Moyamoya disease [Neu] 💬 "Occlusive disease in circle of Willis" | 17 17 trials | 3 / 2 / 1 / 3 💬 | 22 22 drugs [ 17 17 drugs ] | 33 33 genes 45 pathways | 13544 13,544 patientsAge distribution💬 |
23 | Prion disease [Neu] 💬 "Creutzfeldt-Jakob disease", "CJD", "Sporadic Creutzfeldt-Jakob disease", "Sporadic CJD", "sCJD", "Gerstmann-Straussler-Scheinker syndrome", "GSS", "Fatal familial insomnia", "FFI", "Environmentally acquired CJD", "Kuru disease", "Iatrogenic CJD", "iCJD", "Variant CCJD", "vCJD" | 4 4 trials | 0 / 1 / 0 / 0 💬 | 5 5 drugs [ 2 2 drugs ] | 0 - | 464 464 patientsAge distribution💬 |
24 | Subacute sclerosing panencephalitis [Neu] 💬 "SSPE" | 0 - | 0 - | 0 - | 58 58 patientsAge distribution💬 |
25 | Progressive multifocal leukoencephalopathy [Neu] 💬 "PML", "Leukoencephalopathy, progressive multifocal" | 26 26 trials | 3 / 8 / 0 / 2 💬 | 35 35 drugs [ 22 22 drugs ] | 8 8 genes 37 pathways | 77 77 patientsAge distribution💬 |
26 | HTLV-1-associated myelopathy [Neu] 💬 "Tropical spastic paraparesis", "HTLV-1", "HTLV-I-associated myelopathy", "HAM" | 29 29 trials | 10 / 15 / 10 / 0 💬 | 47 47 drugs [ 29 29 drugs ] | 34 34 genes 119 pathways | 1016 1,016 patientsAge distribution💬 |
27 | Idiopathic basal ganglia calcification [Neu] 💬 "IBGC", "Fahr disease", "Familial idiopathic basal ganglia calcification", "FIBGC", "Primary familial brain calcification", "PFBC" | 1 1 trial | 0 / 1 / 0 / 0 💬 | 1 1 drug [ 1 1 drug ] | 0 - | 123 123 patientsAge distribution💬 |
29 | Ullrich disease [Neu] 💬 "Ullrich congenital muscular dystrophy", "Collagen VI-related myopathy" | 0 - | 0 - | 0 - | 19 19 patientsAge distribution💬 |
30 | Distal myopathy [Neu] 💬 "Distal muscular dystrophy", "Miyoshi myopathy", "Distal dysferlinopathy", "Distal myopathy with rimmed vacuoles", "DMRV/GNE myopathy", "Oculopharyngodistal myopathy" | 15 15 trials | 1 / 5 / 12 / 0 💬 | 17 17 drugs [ 3 3 drugs ] | 1 1 gene 1 pathway | 315 315 patientsAge distribution💬 |
31 | Bethlem myopathy [Neu] 💬 "Beth Rem myopathy" | 0 - | 0 - | 0 - | 21 21 patientsAge distribution💬 |
32 | Autophagic vacuolar myopathy [Neu] 💬 "Danon disease", "X-linked myopathy with excessive autophagy", "XMEA" | 1 1 trial | 1 / 0 / 0 / 0 💬 | 1 1 drug [ 0 - ] | 0 - | 9 9 patientsAge distribution💬 |
33 | Schwartz-Jampel syndrome [Neu] 💬 "Schwarz-Yanperu syndrome", "SJS", "Myotonic chondrodystrophy", "Cartilage dystrophic myotonia", "Schwartz-Jampel syndrome type 1", "SJS type 1", "Schwartz-Jampel syndrome type 2", "SJS type 2", "Stuve-Wiedemann syndrome", "Stüve-Wiedemann syndrome" | 0 - | 0 - | 0 - | 1 1 patientAge distribution💬 |
111 | Congenital myopathy [Neu] 💬 "Nemaline myopathy", "Central core disease", "Minicore myopathy", "Multi-minicore myopathy", "Myotubular myopathy", "X-linked myotubular myopathy", "XLMTM", "Centronuclear myopathy", "CNM", "Congenital fiber-type disproportion myopathy" | 10 10 trials | 11 / 8 / 1 / 2 💬 | 17 17 drugs [ 5 5 drugs ] | 1 1 gene 9 pathways | 377 377 patientsAge distribution💬 |
112 | Marinesco-Sjogren syndrome [Neu] 💬 "Hereditary cerebellar ataxia-childhood cataracts" | 0 - | 0 - | 0 - | 4 4 patientsAge distribution💬 |
113 | Muscular dystrophy [Neu] 💬 "Dystrophinopathies", "Duchenne muscular dystrophy", "DMD", "Becker muscular dystrophy", "Limb-girdle muscular dystrophy", "Myotilinopathy", "Laminopathy", "Caveolinopathy", "Limb gridle muscular dystrophy 1C", "LGMD1C", "Desminopathy", "Sarcoglycanopathy", "α-dystroglycanopathy", "Congenital muscular dystrophy", "Facioscapulohumeral muscular dystrophy", "Emery-Dreifuss muscular dystrophy", "Oculopharyngeal muscular dystrophy", "Fukuyama-type congenital muscular dystrophy", "FCMD", "Walker-Warburg syndrome", "Muscle-eye-brain disease", "Myotonic dystrophy", "Integrin α7 deficient CMD", "CIntegrin α7 deficient ongenital muscular dystrophy", "Merosin-deficient congenital muscular dystrophy", "Ullrich congenital muscular dystrophy", "Rigid spine syndrome", "Dynamin 2 deficient congenital muscular dystrophy", "Telesonin-deficient congenital muscular dystrophy", "Congenital muscular dystrophy with mitochondrial structural abnormalities" | 646 646 trials | 401 / 281 / 275 / 65 💬 | 471 471 drugs [ 105 105 drugs ] | 59 59 genes 170 pathways | 5444 5,444 patientsAge distribution💬 |
114 | Non-dystrophic myotonia syndrome [Neu] 💬 "Non-dystrophic Myotonia", "Myotonia congenita", "Thomsen disease", "Autosomal-dominant myotonia congenita", "Becker disease", "Autosomal-recessive myotonia congenita", "Paramyotonia congenita", "Sodium channel myotonia" | 13 13 trials | 1 / 3 / 5 / 0 💬 | 19 19 drugs [ 5 5 drugs ] | 18 18 genes 10 pathways | 29 29 patientsAge distribution💬 |
115 | Hereditary periodic paralysis [Neu] 💬 "Hereditary Hypokalemic Periodic Paralysis", "Andersen-Tawil syndrome", "Hereditary Hyperkalemic Periodic Paralysis" | 1 1 trial | 1 / 0 / 0 / 0 💬 | 2 2 drugs [ 2 2 drugs ] | 13 13 genes 7 pathways | 66 66 patientsAge distribution💬 |
116 | Atopic myelitis [Neu] 💬 "Idiopathic eosinophilic myelitis" | 0 - | 0 - | 0 - | 54 54 patientsAge distribution💬 |
117 | Syringomyelia [Neu] 💬 "Symptomatic syringomyelia", "Asymptomatic syringomyelia", "Syringomyelia with Chiari I malformation", "Syringomyelia with Chiari II malformation", "Syringomyelia without Chiari malformation", "Secondary syringomyelia", "Idiopathic syringomyelia" | 3 3 trials | 0 / 2 / 0 / 0 💬 | 5 5 drugs [ 1 1 drug ] | 0 - | 623 623 patientsAge distribution💬 |
118 | Myelomeningocele [Neu] 💬 "Myeloschisis", "Myelocele", "Myelocystocele", "Syringomyelocele" | 5 5 trials | 1 / 1 / 0 / 1 💬 | 7 7 drugs [ 4 4 drugs ] | 2 2 genes 10 pathways | 137 137 patientsAge distribution💬 |
119 | Isaacs syndrome [Neu] 💬 "Morvan syndrome", "Morvan fibrillary chorea", "Anti-VGKC antibody-associated limbic encephalitis" | 0 - | 0 - | 0 - | 117 117 patientsAge distribution💬 |
120 | Hereditary dystonia [Neu] 💬 "DYT1 dystonia", "DYT2 dystonia", "DYT3 dystonia", "X-linked dystonia-parkinsonism", "Lubag", "DYT4 dystonia", "DYT5 dystonia", "DYT5a dystonia", "DYT5b dystonia", "DYT14 dystonia", "Segawa syndrome", "SS", "Dopa-responsive dystonia", "DRD", "DYT6 dystonia", "DYT7 dystonia", "DYT8 dystonia", "Paroxysmal nonkinesigenic dyskinesia 1", "PNKD1", "DYT9 dystonia", "Paroxysmal dystonic choreathetosis with episodic ataxia and spasticity", "Paroxysmal choreoathetosis and episodic ataxia and spasticity", "CSE", "DYT10 dystonia", "Episodic kinesigenic dyskinesia 1", "EKD1", "DYT11 dystonia", "Myoclonus-dystonia syndrome", "MDS", "DYT12 dystonia", "Rapid-onset dystonia-parkinsonism", "RDP", "Alternating hemiplegia of childhood", "AHC", "Cerebellar ataxia, areflexia, pes cavus, optic atropy, and sensorineural hearing loss", "CAPOS", "DYT13 dystonia", "DYT15 dystonia", "DYT16 dystonia", "DYT17 dystonia", "DYT18 dystonia", "Paroxysmal execise-induced dyskinesia", "PED", "DYT19 dystonia", "Episodic kinesigenic dyskinesia 2", "EKD2", "DYT20 dystonia", "Paroxysmal nonkinesigenic dyskinesia 2", "PNKD2", "Neurodegeneration with Brain Iron Accumulation 1", "Pantothenate kinase-associated neurodegeneration", "PKAN", "Classical PKAN", "Atypical PKAN", "NBIA1", "Hallervorden-Spatz syndrome", "Hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, pallidal degeneration", "Neurodegeneration with Brain Iron Accumulation 2", "Infantile neuroaxonal dystrophy", "INAD", "Classical INAD", "Atypical INAD", "NBIA2", "Karak syndrome", "Neurodegeneration with Brain Iron Accumulation 3", "Neuroferritinopathy", "NBIA3", "Neurodegeneration with Brain Iron Accumulation 4", "Aceruloplasminemia", "Hereditary ceruloplasmin deficiency", "NBIA4", "Neurodegeneration with Brain Iron Accumulation 5", "NBIA5", "Beta-propeller protein-associated neurodegeneration", "BPAN", "Fatty Acid Hydroxylase-associated neurodegeneration", "FAHN", "Dysmyelinating leukodystrophy and spastic paraparasis with or without dystonia, spastic paraplegia 35" | 26 26 trials | 11 / 3 / 18 / 3 💬 | 19 19 drugs [ 3 3 drugs ] | 2 2 genes 2 pathways | 129 129 patientsAge distribution💬 |
121 | Neuroferritinopathy [Neu] 💬 | 0 - | 0 - | 0 - | 2 2 patientsAge distribution💬 |
122 | Superficial siderosis [Neu] 💬 "SS", "Classical superficial siderosis", "Classical SS", "Brain table hemosiderosis" | 3 3 trials | 0 / 0 / 0 / 0 💬 | 3 3 drugs [ 2 2 drugs ] | 0 - | 227 227 patientsAge distribution💬 |
123 | Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy [Neu] 💬 "CARASIL", "Cerebral autosomal recessive arteriopathy with baldness and degenerative spondylosis", "Autosomal recessive leukoencephalopathy with baldness and degenerative spondylosis", "Cerebral autosomal recessive arteriopathy", "Autosomal recessive leukoencephalopathy" | 0 - | 0 - | 0 - | 6 6 patientsAge distribution💬 |
124 | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy [Neu] 💬 "CADASIL", "Autosomal dominant cerebral artery disease with subcortical infarct and leukoencephalopathy", "Autosomal dominant cerebral artery disease" | 12 12 trials | 10 / 7 / 2 / 2 💬 | 14 14 drugs [ 5 5 drugs ] | 3 3 genes 11 pathways | 223 223 patientsAge distribution💬 |
125 | Hereditary diffuse leukoencephalopathy with spheroid [Neu] 💬 "HDLS", "Hereditary diffuse leukoencephalopathy" | 1 1 trial | 0 / 1 / 0 / 0 💬 | 9 9 drugs [ 1 1 drug ] | 0 - | 68 68 patientsAge distribution💬 |
126 | Perry syndrome [Neu] 💬 | 0 - | 0 - | 0 - | 3 3 patientsAge distribution💬 |
127 | Frontotemporal lobar degeneration [Neu] 💬 "Frontotemporal dementia", "Semantic dementia" | 90 90 trials | 32 / 36 / 31 / 8 💬 | 87 87 drugs [ 30 30 drugs ] | 39 39 genes 88 pathways | 1352 1,352 patientsAge distribution💬 |
128 | Bickerstaff brainstem encephalitis [Neu] 💬 | 0 - | 0 - | 0 - | 78 78 patientsAge distribution💬 |
129 | Acute encephalopathy with biphasic seizures and late reduced diffusion [Neu] 💬 "Epilepticus type biphasic acute encphalopathy", "Epilepticus type acute encphalopathy" | 1 1 trial | 0 / 1 / 0 / 0 💬 | 1 1 drug [ 1 1 drug ] | 0 - | 47 47 patientsAge distribution💬 |
130 | Congenital insensitivity to pain with anhydrosis [Neu] 💬 "CIPA", "Hereditary sensory and autonomic neuropathy type IV", "HSAN4", "Hereditary sensory and autonomic neuropathy type V", "HSAN5" | 0 - | 0 - | 0 - | 45 45 patientsAge distribution💬 |
131 | Alexander disease [Neu] 💬 "ALXDRD", "AxD", "Alexander Disease type 1", "ALXDRD1", "AxD1", "Alexander Disease type 2", "ALXDRD2", "AxD2", "Alexander disease type 3", "ALXDRD3", "AxD3" | 4 4 trials | 3 / 3 / 4 / 0 💬 | 4 4 drugs [ 1 1 drug ] | 0 - | 50 50 patientsAge distribution💬 |
132 | Congenital supranuclear bulbar palsy [Neu] 💬 "Congenital suprabulbar paresis", "Worcester drought syndrome", "Worster-Drought syndrome" | 0 - | 0 - | 0 - | 7 7 patientsAge distribution💬 |
133 | Moebius syndrome [Neu] 💬 "Mobius syndrome", "Möbius syndrome" | 0 - | 0 - | 0 - | 14 14 patientsAge distribution💬 |
135 | Aicardi syndrome [Neu] 💬 | 1 1 trial | 0 / 1 / 0 / 0 💬 | 9 9 drugs [ 3 3 drugs ] | 0 - | 13 13 patientsAge distribution💬 |
136 | Hemimegalencephaly [Neu] 💬 "Unilateral megalencephaly" | 0 - | 0 - | 0 - | 23 23 patientsAge distribution💬 |
137 | Focal cortical dysplasia [Neu] 💬 "FCD", "FCD type 1a", "FCD type 1b", "FCD type 1c", "FCD type 2a", "FCD type 2b", "FCD type 3a", "FCD type 3b", "FCD type 3c", "FCD type 3d" | 9 9 trials | 0 / 6 / 0 / 0 💬 | 5 5 drugs [ 3 3 drugs ] | 1 1 gene 51 pathways | 77 77 patientsAge distribution💬 |
138 | Nerve cell migration disorder [Neu] 💬 "Lissencephaly", "Neuronal migration defect", "Classical lissencephaly", "Ectopic gray matter", "Subcortical ectopic gray matter", "Periventricular nodular ectopic gray matter", "Polymicrogyria", "Cortical dysplasia with cobblestone appearance", "Schizencephaly", "Porencephaly", "Miller-Dieker syndrome", "Perisylvian polymicrogyria", "X-linked Lissencephaly" | 1 1 trial | 0 / 1 / 0 / 0 💬 | 2 2 drugs [ 1 1 drug ] | 1 1 gene 106 pathways | 76 76 patientsAge distribution💬 |
139 | Congenital cerebral hypomyelination [Neu] 💬 "Congenital cerebral white matter aplasia", "Pelizaeus-Merzbacher disease", "Pelizaeus-Merzbacher-like disease 1", "Pelizaeus-Merzbacher-like disease type 1", "Hypomyelination with atrophy of the basal ganglia and cerebellum", "18q-syndrome", "Chromosome 18q deletion syndrome", "Allan-Herndon-Dudley syndrome", "Mitochondrial Hsp60 chaperonopathy", "Salla disease", "Free sialic acid storage disease", "Diffuse cerebral hypomyelination with cerebellar atrophy and hypoplasia of the corpus callosum", "Hypomyelination and congenital cataract", "Ataxia, delayed dentition, and hypomyelination", "Peripheral demyelinating neuropathy", "Central dysmyelinating leukodystrophy", "Waardenburg syndrome", "Hirschsprung disease" | 10 10 trials | 1 / 7 / 0 / 0 💬 | 7 7 drugs [ 2 2 drugs ] | 2 2 genes 2 pathways | 44 44 patientsAge distribution💬 |
140 | Dorabe syndrome [Neu] 💬 "Dravet syndrome" | 116 116 trials | 46 / 25 / 80 / 11 💬 | 65 65 drugs [ 17 17 drugs ] | 50 50 genes 64 pathways | 84 84 patientsAge distribution💬 |
141 | Mesial temporal lobe epilepsy with hippocampal sclerosis [Neu] 💬 "Medial temporal lobe epilepsy with hippocampal sclerosis", "Mesial temporal lobe epilepsy with bilateral hippocampal sclerosis", "Medial temporal lobe epilepsy" | 1 1 trial | 1 / 1 / 0 / 0 💬 | 1 1 drug [ 0 - ] | 0 - | 72 72 patientsAge distribution💬 |
142 | Myoclonic absence epilepsy [Neu] 💬 | 0 - | 0 - | 0 - | 4 4 patientsAge distribution💬 |
143 | Epilepsy with myoclonic-atonic seizure [Neu] 💬 "Epilepsy with myoclonic cataplexy" | 0 - | 0 - | 0 - | 19 19 patientsAge distribution💬 |
144 | Lennox-Gastaut syndrome [Neu] 💬 | 111 111 trials | 35 / 17 / 79 / 8 💬 | 72 72 drugs [ 14 14 drugs ] | 49 49 genes 61 pathways | 348 348 patientsAge distribution💬 |
145 | West syndrome [Neu] 💬 "Infantile spasm" | 43 43 trials | 16 / 15 / 18 / 9 💬 | 52 52 drugs [ 15 15 drugs ] | 28 28 genes 26 pathways | 290 290 patientsAge distribution💬 |
146 | Ohtahara syndrome [Neu] 💬 "Early infantile epileptic encephalopathy with suppression burst" | 0 - | 0 - | 0 - | 21 21 patientsAge distribution💬 |
147 | Early myoclonic encephalopathy [Neu] 💬 | 0 - | 0 - | 0 - | 9 9 patientsAge distribution💬 |
148 | Epilepsy of infancy with migrating focal seizure [Neu] 💬 "Infant epilepsy with migratory focus seizure", "Migrating partial seizures in infancy", "Infant epilepsy" | 0 - | 0 - | 0 - | 18 18 patientsAge distribution💬 |
149 | Hemiconvulsion hemiplegia epilepsy syndrome [Neu] 💬 "One side convulsions", "Hemiplegia", "Epilepsy syndrome" | 25 25 trials | 3 / 4 / 8 / 3 💬 | 35 35 drugs [ 13 13 drugs ] | 16 16 genes 22 pathways | 33 33 patientsAge distribution💬 |
150 | Ring chromosome 20 epilepsy syndrome [Neu] 💬 "Ring chromosome 20 syndrome" | 0 - | 0 - | 0 - | 12 12 patientsAge distribution💬 |
151 | Rasmussen encephalitis [Neu] 💬 | 1 1 trial | 0 / 1 / 1 / 0 💬 | 2 2 drugs [ 1 1 drug ] | 5 5 genes 33 pathways | 48 48 patientsAge distribution💬 |
152 | PCDH19 related syndrome [Neu] 💬 "PCDH19 Epilepsy", "Epilepsy and mental retardation limited to females", "PCDH19 female pediatric epilepsy", "PCDH19-related epilepsy", "Protocadherin 19 (PCDH19)-related epilepsy" | 10 10 trials | 5 / 5 / 5 / 1 💬 | 7 7 drugs [ 1 1 drug ] | 16 16 genes 7 pathways | 12 12 patientsAge distribution💬 |
153 | Acute encephalitis with refractory, repetitive partial seizure [Neu] 💬 repetitive partial seizure", "AERRPS", "Refractory frequent partial seizures intussusception acute encephalitis", "Febrile infection related epilepsy syndrome", "FIRES", "New onset refractory status epilepsy syndrome", "NORSE syndrome" | 0 - | 0 - | 0 - | 65 65 patientsAge distribution💬 |
154 | Epilepsy with continuous spikes and waves during slow sleep [Neu] 💬 "Epileptic encephalopathy with continuous spike-and-wave during sleep" | 7 7 trials | 0 / 7 / 0 / 0 💬 | 4 4 drugs [ 3 3 drugs ] | 13 13 genes 7 pathways | 21 21 patientsAge distribution💬 |
155 | Acquired aphasia with convulsive disorder [Neu] 💬 "Landau-Kleffner syndrome" | 1 1 trial | 0 / 1 / 1 / 0 💬 | 2 2 drugs [ 2 2 drugs ] | 29 29 genes 14 pathways | 4 4 patientsAge distribution💬 |
156 | Rett syndrome [Neu] 💬 "Typical Rett syndrome", "Atypical Rett syndrome" | 44 44 trials | 4 / 24 / 16 / 0 💬 | 61 61 drugs [ 23 23 drugs ] | 57 57 genes 83 pathways | 109 109 patientsAge distribution💬 |
157 | Sturge-Weber syndrome [Neu] 💬 "Síndrome de Sturge-Weber" | 10 10 trials | 3 / 6 / 1 / 1 💬 | 13 13 drugs [ 4 4 drugs ] | 5 5 genes 63 pathways | 75 75 patientsAge distribution💬 |
158 | Tuberous sclerosis [Neu] 💬 "Tuberous sclerosis complex" | 112 112 trials | 49 / 40 / 55 / 17 💬 | 71 71 drugs [ 19 19 drugs ] | 35 35 genes 118 pathways | 1017 1,017 patientsAge distribution💬 |
177 | Joubert syndrome related disorder [Neu] 💬 "Joubert syndrome and related disorder", "Joubert syndrome", "JSRD", "Arima syndrome", "Senior-Loken syndrome", "Senior-Løken syndrome", "COACH syndrome", "Orofaciodigital syndrome" | 1 1 trial | 0 / 0 / 0 / 0 💬 | 1 1 drug [ 0 - ] | 0 - | 16 16 patientsAge distribution💬 |
201 | Angelman syndrome [Neu] 💬 | 25 25 trials | 9 / 8 / 5 / 0 💬 | 40 40 drugs [ 11 11 drugs ] | 22 22 genes 20 pathways | 29 29 patientsAge distribution💬 |
263 | Cerebrotendinous xanthomatosis [Neu] 💬 "27-hydroxylase deficiency", "CYP27 deficiency" | 6 6 trials | 0 / 1 / 2 / 0 💬 | 11 11 drugs [ 2 2 drugs ] | 2 2 genes 4 pathways | 48 48 patientsAge distribution💬 |
307 | Canavan disease [Neu] 💬 | 6 6 trials | 3 / 3 / 0 / 0 💬 | 11 11 drugs [ 5 5 drugs ] | 2 2 genes 2 pathways | - |
308 | Progressive leukoencephalopathy [Neu] 💬 "Megalencephalic leukoencephalopathy with subcortical cyst", "Leukoencephalopathy with vanishing white matter", "Leukoencephalopathy, progressive, with ovarian failure" | 0 - | 0 - | 0 - | 20 20 patientsAge distribution💬 |
309 | Progressive myoclonus epilepsy [Neu] 💬 "Unverricht-Lundborg disease", "Lafora disease", "Benign adult familial myoclonus epilepsy", "BAFME" | 11 11 trials | 0 / 0 / 6 / 0 💬 | 15 15 drugs [ 2 2 drugs ] | 4 4 genes 9 pathways | 43 43 patientsAge distribution💬 |
320 | Inherited glycosylphosphatidylinositol deficiency [Neu] 💬 "Inherited GPI deficiency", "IGD", "Congenital glycosylphosphatidylinositol deficiency", "Congenital GPI deficiency" | 3 3 trials | 0 / 0 / 0 / 0 💬 | 2 2 drugs [ 2 2 drugs ] | 0 - | 1 1 patientAge distribution💬 |
334 | Cerebral creatine deficiency syndrome [Neu] 💬 "CCDS" | 0 - | 0 - | 0 - | - |